Loading...

Thomas Marcotte

Title(s)Professor In Residence, Psychiatry
SchoolHealth Sciences
Phone619-543-5044
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Marcotte is Professor of Psychiatry at the University of California, San Diego, and Co-Director of the Center for Medicinal Cannabis Research, which has conducted clinical trials of cannabis for almost 20 years, and has an active, ongoing portfolio exploring the effects of cannabinoids (plant-based, synthetic) in various medical/psychiatric conditions. He is currently the principal investigator on studies addressing cannabis for the treatment of pain, and the effects of acute cannabis use on driving performance. He has previously been co-investigator on cannabis studies addressing pain and spasticity in multiple sclerosis. He has been the PI on numerous HIV studies over the years, including projects aimed at examining ART initiation in India, the development of brief screening tools for HAND, and studies examining the impact of HAND on real-world functioning. Dr. Marcotte has developed techniques for assessing the most complex of everyday tasks, driving an automobile, and examined the types of deficits that may predispose an individual to impaired driving abilities. He has also designed tablet-based tools for assessing cognitive impairment. He co-edited the book Neuropsychology of Everyday Functioning.

    Dr. Marcotte previously served as the Center Manager of the HIV Neurobehavioral Research Center (1996-2018), and Co-Director of CHARTER (a national multi-site study of the CNS impact of treatments for HIV). Dr. Marcotte has been on on the editorial boards of Neuropsychology and the Journal of the International Neuropsychological Society.

    Collapse Research 
    Collapse Research Activities and Funding
    A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
    NIH/NIDA R01DA038634Sep 1, 2015 - Jul 31, 2020
    Role: Principal Investigator
    Remediation of HAND: Initial efficacy, real-world relevance, and mechanisms
    NIH/NIMH R34MH097567Jun 3, 2013 - May 31, 2016
    Role: Principal Investigator
    A brief iPad-based screening measure for HIV-associated neurocognitive disorders
    NIH/NIMH R42MH099964Apr 1, 2013 - Aug 31, 2018
    Role: Principal Investigator
    A brief iPad-based screening measure for HIV-associated neurocognitive disorders
    NIH/NIMH R41MH099964Apr 1, 2013 - Mar 31, 2014
    Role: Principal Investigator
    NeuroAIDS in India
    NIH/NIMH R01MH078748Jun 1, 2007 - May 31, 2013
    Role: Principal Investigator
    Development of Simulations to Detect Impaired Drivers
    NIH/NIMH R42MH057593Sep 30, 1997 - Aug 31, 2006
    Role: Principal Investigator
    DEVELOPMENT OF SIMULATIONS TO DETECT IMPAIRED DRIVERS
    NIH/NIMH R41MH057593Sep 30, 1997 - Mar 31, 2000
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Temereanca A, Ene L, Rosca A, Diaconu CC, Luca A, Burlacu R, Radoi R, Bulacu-Talnariu A, Marcotte T, Achim C, Ruta S. Neurocognitive impairment in the cART era in a Romanian cohort of young adults with chronic HIV infection. AIDS Res Hum Retroviruses. 2019 Sep 03. PMID: 31476875.
      View in: PubMed
    2. Burlacu R, Umlauf A, Marcotte TD, Soontornniyomkij B, Diaconu CC, Bulacu-Talnariu A, Temereanca A, Ruta SM, Letendre S, Ene L, Achim CL. Plasma CXCL10 correlates with HAND in HIV-infected women. J Neurovirol. 2019 Aug 14. PMID: 31414350.
      View in: PubMed
    3. Dastgheyb RM, Sacktor N, Franklin D, Letendre S, Marcotte T, Heaton R, Grant I, McArthur J, Rubin LH, Haughey NJ. Cognitive trajectory phenotypes in human immunodeficiency virus infected patients. J Acquir Immune Defic Syndr. 2019 Apr 29. PMID: 31107302.
      View in: PubMed
    4. Tyree GA, Sarkar R, Bellows BK, Ellis RJ, Atkinson JH, Marcotte TD, Wallace MS, Grant I, Shi Y, Murphy JD, Grelotti DJ. A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain. Cannabis Cannabinoid Res. 2019; 4(1):62-72. PMID: 30944870.
      View in: PubMed
    5. Khuder SS, Chen S, Letendre S, Marcotte T, Grant I, Franklin D, Rubin LH, Margolick JB, Jacobson LP, Sacktor N, D'Souza G, Stosor V, Lake JE, Rapocciolo G, McArthur JC, Dickens AM, Haughey NJ. Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients. Neurology. 2019 Mar 19; 92(12):e1344-e1353. PMID: 30787163.
      View in: PubMed
    6. Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, Ghate M, Abimiku A, Charurat M, Letendre S, Ellis RJ, Mehendale S, Blattner WA, Royal W, Marcotte TD, Heaton RK, Grant I, McCutchan JA. Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria. J Acquir Immune Defic Syndr. 2019 Feb 01; 80(2):e30-e35. PMID: 30422905.
      View in: PubMed
    7. Rupp G, Berka C, Meghdadi AH, Karic MS, Casillas M, Smith S, Rosenthal T, McShea K, Sones E, Marcotte TD. EEG-Based Neurocognitive Metrics May Predict Simulated and On-Road Driving Performance in Older Drivers. Front Hum Neurosci. 2018; 12:532. PMID: 30697156.
      View in: PubMed
    8. Sobolesky PM, Smith BE, Hubbard JA, Stone J, Marcotte TD, Grelotti DJ, Grant I, Fitzgerald RL. Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid. Clin Chim Acta. 2019 Apr; 491:30-38. PMID: 30615854.
      View in: PubMed
    9. Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 Feb; 25(1):32-41. PMID: 30291567.
      View in: PubMed
    10. Burlacu R, Umlauf A, Luca A, Gianella S, Radoi R, Ruta SM, Marcotte TD, Ene L, Achim CL. Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS. 2018 Jan 14; 32(2):217-225. PMID: 29112063.
      View in: PubMed
    11. Kamat R, McCutchan A, Kumarasamy N, Marcotte TD, Umlauf A, Selvamuthu P, Meyer R, Letendre S, Heaton R, Bharti AR. Neurocognitive functioning among HIV-positive adults in southern India. J Neurovirol. 2017 10; 23(5):750-755. PMID: 28681344.
      View in: PubMed
    12. Dawson DR, Marcotte TD. Special issue on ecological validity and cognitive assessment. Neuropsychol Rehabil. 2017 07; 27(5):599-602. PMID: 28480821.
      View in: PubMed
    13. Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte T, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, Tharakan R, McArthur JC, Fox H, Haughey NJ. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 06 19; 31(10):1365-1378. PMID: 28574961.
      View in: PubMed
    14. Wilsey BL, Deutsch R, Samara E, Marcotte TD, Barnes AJ, Huestis MA, Le D. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. J Pain Res. 2016; 9:587-98. PMID: 27621666; PMCID: PMC5012851.
    15. Ene L, Marcotte TD, Umlauf A, Grancea C, Temereanca A, Bharti A, Achim CL, Letendre S, Ruta SM. Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. J Neuroimmunol. 2016 10 15; 299:1-7. PMID: 27725106.
      View in: PubMed
    16. Wilsey B, Deutsch R, Marcotte TD. Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids. Cannabis Cannabinoid Res. 2016; 1(1):139-148. PMID: 28861490.
      View in: PubMed
    17. Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre SL, Gisslén M. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016; 11(6):e0157160. PMID: 27295036; PMCID: PMC4905676.
    18. Wilsey B, Marcotte TD, Deutsch R, Zhao H, Prasad H, Phan A. An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. J Pain. 2016 09; 17(9):982-1000. PMID: 27286745.
      View in: PubMed
    19. Hoenigl M, de Oliveira MF, Pérez-Santiago J, Zhang Y, Morris S, McCutchan AJ, Finkelman M, Marcotte TD, Ellis RJ, Gianella S. (1?3)-ß-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study. Medicine (Baltimore). 2016 Mar; 95(11):e3162. PMID: 26986173.
      View in: PubMed
    20. Wilsey B, Atkinson JH, Marcotte TD, Grant I. The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document. Clin J Pain. 2015 Dec; 31(12):1087-96. PMID: 25370134; PMCID: PMC4417655 [Available on 12/01/16].
    21. Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH. Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. J Pain. 2015 Jul; 16(7):616-27. PMID: 25843054.
      View in: PubMed
    22. Dickens AM, Anthony DC, Deutsch R, Mielke MM, Claridge TD, Grant I, Franklin D, Rosario D, Marcotte T, Letendre S, McArthur JC, Haughey NJ. Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS. 2015 Mar 13; 29(5):559-69. PMID: 25611149.
      View in: PubMed
    23. Ghate M, Mehendale S, Meyer R, Umlauf A, Deutsch R, Kamat R, Thakar M, Risbud A, Kulkarni S, Sakamoto M, Alexander T, Franklin D, Letendre S, Heaton RK, Grant I, Marcotte TD. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India. J Neurovirol. 2015 Aug; 21(4):391-8. PMID: 25750072; PMCID: PMC4512904.
    24. Heaton RK, Franklin DR, Deutsch R, Letendre SL, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I. Reply to Haddow et al. Clin Infect Dis. 2015 May 01; 60(9):1442-3. PMID: 25645217.
      View in: PubMed
    25. Kamat R, Cattie JE, Marcotte TD, Woods SP, Franklin DR, Corkran SH, Ellis RJ, Grant I, Heaton RK. Incident major depressive episodes increase the severity and risk of apathy in HIV infection. J Affect Disord. 2015 Apr 01; 175:475-80. PMID: 25679203; PMCID: PMC4386921.
    26. Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 Feb 01; 60(3):473-80. PMID: 25362201.
      View in: PubMed
    27. Kamat R, Brown GG, Bolden K, Fennema-Notestein C, Archibald S, Marcotte TD, Letendre SL, Ellis RJ, Woods SP, Grant I, Heaton RK. Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection. J Clin Exp Neuropsychol. 2014; 36(8):854-66. PMID: 25275424; PMCID: PMC4303236.
    28. Ene L, Franklin DR, Burlacu R, Luca AE, Blaglosov AG, Ellis RJ, Alexander TJ, Umlauf A, Grant I, Duiculescu DC, Achim CL, Marcotte TD. Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood. J Neurovirol. 2014 Oct; 20(5):496-504. PMID: 25185868; PMCID: PMC4324616.
    29. Morgan EE, Doyle KL, Minassian A, Henry BL, Perry W, Marcotte TD, Woods SP, Grant I. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Psychiatry Res. 2014 Dec 15; 220(1-2):527-34. PMID: 25081313; PMCID: PMC4252574.
    30. Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 Jun 10; 82(23):2055-62. PMID: 24814848.
      View in: PubMed
    31. Tilghman MW, Bhattacharya J, Deshpande S, Ghate M, Espitia S, Grant I, Marcotte TD, Smith D, Mehendale S. Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function. J Med Virol. 2014 Jan; 86(1):88-96. PMID: 24150902; PMCID: PMC3872113.
    32. Marcotte TD, Deutsch R, Michael BD, Franklin D, Cookson DR, Bharti AR, Grant I, Letendre SL. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 Dec; 8(5):1123-35. PMID: 24101401; PMCID: PMC3874146.
    33. Wilsey B, Marcotte T, Deutsch R. Response to Stacey and Moller's letter to the editor. J Pain. 2013 Oct; 14(10):1252-3. PMID: 24090992; PMCID: PMC4161205.
    34. Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS. 2013 Sep 24; 27(15):2385-401. PMID: 23751261; PMCID: PMC3814629.
    35. Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC. Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):282-92. PMID: 23202813.
      View in: PubMed
    36. Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, Pardo CA, Paul RH, Pulliam L, Robertson K, Royal W, Sacktor N, Sithinamsuwan P, Smith DM, Valcour V, Wigdahl B, Wood C. Global NeuroAIDS roundtable. J Neurovirol. 2013 Feb; 19(1):1-9. PMID: 23354550; PMCID: PMC3713197.
    37. Foley JM, Gooding AL, Thames AD, Ettenhofer ML, Kim MS, Castellon SA, Marcotte TD, Sadek JR, Heaton RK, van Gorp WG, Hinkin CH. Visuospatial and Attentional Abilities Predict Driving Simulator Performance Among Older HIV-infected Adults. Am J Alzheimers Dis Other Demen. 2013 Mar; 28(2):185-94. PMID: 23314403.
      View in: PubMed
    38. Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson D, Grant I. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 Jan 01; 62(1):36-42. PMID: 23111573; PMCID: PMC3529802.
    39. Kamat R, Morgan E, Marcotte TD, Badiee J, Maich I, Cherner M, de Almeida S, de Pereira AP, Ribeiro CE, Barbosa F, Atkinson JH, Ellis R. Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil. J Affect Disord. 2013 Sep 25; 150(3):1069-75. PMID: 23245465.
      View in: PubMed
    40. Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013 Feb; 14(2):136-48. PMID: 23237736.
      View in: PubMed
    41. Kamat R, Woods SP, Marcotte TD, Ellis RJ, Grant I. Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Arch Clin Neuropsychol. 2012 Aug; 27(5):520-31. PMID: 22705481; PMCID: PMC3399510.
    42. Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012 Jul 10; 184(10):1143-50. PMID: 22586334; PMCID: PMC3394820.
    43. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 Apr; 18(2):81-90. PMID: 22528397.
      View in: PubMed
    44. Marcotte TD, Bekman NM, Meyer RA, Brown SA. High-risk driving behaviors among adolescent binge drinkers. Am J Drug Alcohol Abuse. 2012 Jul; 38(4):322-7. PMID: 22324748; PMCID: PMC3741039.
    45. Kamat R, Ghate M, Gollan TH, Meyer R, Vaida F, Heaton RK, Letendre S, Franklin D, Alexander T, Grant I, Mehendale S, Marcotte TD. Effects of Marathi-Hindi bilingualism on neuropsychological performance. J Int Neuropsychol Soc. 2012 Mar; 18(2):305-13. PMID: 22206622; PMCID: PMC3581332.
    46. Cheng S, Klein H, Bartsch DU, Kozak I, Marcotte TD, Freeman WR. Relationship between retinal nerve fiber layer thickness and driving ability in patients with human immunodeficiency virus infection. Graefes Arch Clin Exp Ophthalmol. 2011 Nov; 249(11):1643-7. PMID: 21732109; PMCID: PMC4144406.
    47. Scott JC, Woods SP, Vigil O, Heaton RK, Schweinsburg BC, Ellis RJ, Grant I, Marcotte TD. A neuropsychological investigation of multitasking in HIV infection: implications for everyday functioning. Neuropsychology. 2011 Jul; 25(4):511-9. PMID: 21401259; PMCID: PMC3125422.
    48. Scott JC, Woods SP, Vigil O, Heaton RK, Grant I, Ellis RJ, Marcotte TD. Script generation of activities of daily living in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc. 2011 Jul; 17(4):740-5. PMID: 22882813; PMCID: PMC3419482.
    49. Thames AD, Becker BW, Marcotte TD, Hines LJ, Foley JM, Ramezani A, Singer EJ, Castellon SA, Heaton RK, Hinkin CH. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol. 2011 Feb; 25(2):224-43. PMID: 21331979; PMCID: PMC3616492.
    50. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 Feb; 17(1):3-16. PMID: 21174240.
      View in: PubMed
    51. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010 Dec 07; 75(23):2087-96. PMID: 21135382.
      View in: PubMed
    52. Atkinson JH, Jin H, Shi C, Yu X, Duarte NA, Casey CY, Franklin DR, Vigil O, Cysique L, Wolfson T, Riggs PK, Gupta S, Letendre S, Marcotte TD, Grant I, Wu Z, Heaton RK. Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China. J Affect Disord. 2011 May; 130(3):421-8. PMID: 21094530; PMCID: PMC3307799.
    53. Foley JM, Wright MJ, Gooding AL, Ettenhofer M, Kim M, Choi M, Castellon SA, Sadek J, Heaton RK, van Gorp WG, Marcotte TD, Hinkin CH. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia. Int Psychogeriatr. 2011 Jun; 23(5):835-43. PMID: 21092351.
      View in: PubMed
    54. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2010 Mar; 16(2):185-8. PMID: 20443740; PMCID: PMC4386597.
    55. Dawes SE, Suarez P, Vaida F, Marcotte TD, Atkinson JH, Grant I, Heaton R, Cherner M. Demographic influences and suggested cut-scores for the Beck Depression Inventory in a non-clinical Spanish speaking population from the US-Mexico border region. Int J Cult Ment Health. 2010; 3(1):34-42. PMID: 24432048.
      View in: PubMed
    56. Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):154-63. PMID: 19815352; PMCID: PMC2814900.
    57. Marcotte, T.D. Grant, I.Neuropsychology of Everyday Functioning. 2009.
    58. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2008 Nov; 14(6):536-49. PMID: 18991068.
      View in: PubMed
    59. Marcotte TD. Cognitive disorders in the era of combination HIV antiviral treatment. Focus. 2008 Sep; 23(3):1-5. PMID: 19062781.
      View in: PubMed
    60. Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2008 Sep; 89(9):1753-8. PMID: 18760160; PMCID: PMC4560356.
    61. Cherner M, Suarez P, Posada C, Fortuny LA, Marcotte T, Grant I, Heaton R. Equivalency of Spanish language versions of the trail making test part B including or excluding "CH". Clin Neuropsychol. 2008 Jul; 22(4):662-5. PMID: 17853122; PMCID: PMC3059802.
    62. Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain. 2008 Jun; 9(6):506-21. PMID: 18403272; PMCID: PMC4968043.
    63. Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK. Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol. 2008 Aug; 30(6):613-26. PMID: 18608689.
      View in: PubMed
    64. Cysique LA, Jin H, Franklin DR, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc. 2007 Sep; 13(5):781-90. PMID: 17697409; PMCID: PMC2857379.
    65. Cherner M, Suarez P, Lazzaretto D, Fortuny LA, Mindt MR, Dawes S, Marcotte T, Grant I, Heaton R. Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol. 2007 Mar; 22(3):343-53. PMID: 17293078; PMCID: PMC3737073.
    66. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol. 2007; 13(1):23-8. PMID: 17454445.
      View in: PubMed
    67. Cysique LA, Deutsch R, Atkinson JH, Young C, Marcotte TD, Dawson L, Grant I, Heaton RK. Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc. 2007 Jan; 13(1):1-11. PMID: 17166298.
      View in: PubMed
    68. Ances BM, Letendre S, Buzzell M, Marquie-Beck J, Lazaretto D, Marcotte TD, Grant I, Ellis RJ. Valproic acid does not affect markers of human immunodeficiency virus disease progression. J Neurovirol. 2006 Oct; 12(5):403-6. PMID: 17065134.
      View in: PubMed
    69. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006 Jul; 129(Pt 7):1872-83. PMID: 16735456.
      View in: PubMed
    70. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006 Apr 04; 20(6):879-87. PMID: 16549972.
      View in: PubMed
    71. Scott JC, Woods SP, Patterson KA, Morgan EE, Heaton RK, Grant I, Marcotte TD. Recency effects in HIV-associated dementia are characterized by deficient encoding. Neuropsychologia. 2006; 44(8):1336-43. PMID: 16504221.
      View in: PubMed
    72. Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S. Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006 Jan; 28(1):13-28. PMID: 16448973.
      View in: PubMed
    73. Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005 Oct; 19 Suppl 3:S72-8. PMID: 16251831.
      View in: PubMed
    74. Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD, Marcotte TL, Heaton RK, Ellis RJ, Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry. 2005 Aug; 162(8):1461-72. PMID: 16055767.
      View in: PubMed
    75. Woods SP, Scott JC, Conover E, Marcotte TD, Heaton RK, Grant I. Test-retest reliability of component process variables within the Hopkins Verbal Learning Test-Revised. Assessment. 2005 Mar; 12(1):96-100. PMID: 15695747.
      View in: PubMed
    76. Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol. 2005 Feb; 79(3):1772-88. PMID: 15650202; PMCID: PMC544082.
    77. Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, Grant I. A multimodal assessment of driving performance in HIV infection. Neurology. 2004 Oct 26; 63(8):1417-22. PMID: 15505158.
      View in: PubMed
    78. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004 Sep; 26(6):759-78. PMID: 15370374.
      View in: PubMed
    79. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004 May; 18(2):234-48. PMID: 15587671.
      View in: PubMed
    80. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004 May; 26(3):307-19. PMID: 15512922.
      View in: PubMed
    81. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31. PMID: 15147590.
      View in: PubMed
    82. Freeman WR, McCutchan JA, Arevalo JF, Wolfson T, Marcotte TD, Heaton RK, Grant I. The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era. Ocul Immunol Inflamm. 2004 Mar; 12(1):25-33. PMID: 15209461; PMCID: PMC1378132.
    83. Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I, Mallory M, Miller A, Jernigan TL. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol. 2004 Mar; 61(3):369-76. PMID: 15023814.
      View in: PubMed
    84. Woods SP, Conover E, Rippeth JD, Carey CL, Gonzalez R, Marcotte TD, Heaton RK, Grant I. Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes? Neuropsychologia. 2004; 42(6):801-9. PMID: 15037058.
      View in: PubMed
    85. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004 Jan; 10(1):1-14. PMID: 14751002.
      View in: PubMed
    86. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):467-74. PMID: 14657756.
      View in: PubMed
    87. Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12. PMID: 14568811.
      View in: PubMed
    88. Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003 Feb; 25(1):122-32. PMID: 12607177; PMCID: PMC3737066.
    89. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003 Jan; 9(1):64-71. PMID: 12570359.
      View in: PubMed
    90. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002 Nov 26; 59(10):1563-7. PMID: 12451198.
      View in: PubMed
    91. Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS. 2002 May 03; 16(7):1019-29. PMID: 11953468; PMCID: PMC3548569.
    92. Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS. 2001 Sep 28; 15(14):1898-9. PMID: 11579260.
      View in: PubMed
    93. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry. 2001 Jan; 58(1):24-32. PMID: 11146755.
      View in: PubMed
    94. Llorente AM, van Gorp WG, Stern MJ, George L, Satz P, Marcotte TD, Calvillo GM, Hinkin CH. Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: results of a randomized, double-blind, placebo-controlled investigation. J Int Neuropsychol Soc. 2001 Jan; 7(1):27-32. PMID: 11253839.
      View in: PubMed
    95. Heaton RK, Temkin N, Dikmen S, Avitable N, Taylor MJ, Marcotte TD, Grant I. Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol. 2001 Jan; 16(1):75-91. PMID: 14590193.
      View in: PubMed
    96. Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, Ellis RJ, Grant I. The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc. 1999 Nov; 5(7):579-92. PMID: 10645701.
      View in: PubMed
    97. Abramson I, Wolfson T, Marcotte TD, Grant I. Extending the p-plot: heuristics for multiple testing. HNRC group. J Int Neuropsychol Soc. 1999 Sep; 5(6):510-7. PMID: 10561931.
      View in: PubMed
    98. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 1999 Apr; 9(2):209-17. PMID: 10219738.
      View in: PubMed
    99. Plummer DJ, Marcotte TD, Sample PA, Wolfson T, Heaton RK, Grant I, Freeman WR. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center. Invest Ophthalmol Vis Sci. 1999 Feb; 40(2):435-42. PMID: 9950603.
      View in: PubMed
    100. van Gorp WG, Marcotte TD, Sultzer D, Hinkin C, Mahler M, Cummings JL. Screening for dementia: comparison of three commonly used instruments. J Clin Exp Neuropsychol. 1999 Feb; 21(1):29-38. PMID: 10420999.
      View in: PubMed
    101. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol. 1997 Dec; 42(6):963-72. PMID: 9403489.
      View in: PubMed
    102. Grant I, Heaton RK, Marcotte TD. Evaluating the neurocognitive complications of SLE. Lessons from HIV disease. Ann N Y Acad Sci. 1997 Aug 14; 823:18-43. PMID: 9292031.
      View in: PubMed
    103. Marcotte TD, van Gorp W, Hinkin CH, Osato S. Concurrent validity of the Neurobehavioral Cognitive Status Exam subtests. J Clin Exp Neuropsychol. 1997 Jun; 19(3):386-95. PMID: 9268813.
      View in: PubMed
    104. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol. 1997 Apr; 54(4):416-24. PMID: 9109743.
      View in: PubMed
    105. Hinkin CH, van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, Campbell L, Baluda MR. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996 Jun; 18(3):431-43. PMID: 8877626.
      View in: PubMed
    106. Hinkin CH, van Gorp WG, Mandelkern MA, Gee M, Satz P, Holston S, Marcotte TD, Evans G, Paz DH, Ropchan JR. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci. 1995; 7(2):180-7. PMID: 7626961.
      View in: PubMed
    107. van Gorp WG, Miller EN, Marcotte TD, Dixon W, Paz D, Selnes O, Wesch J, Becker JT, Hinkin CH, Mitrushina M. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology. 1994 May; 44(5):929-35. PMID: 8190299.
      View in: PubMed